Final Programme - iuphar

FC04 Pharmacoepidemiology, current controversies and
opportunities
Mon 130 Gender differences of ADRs related to psychotropic drug use: A survey from France, Italy and Spain
Paola D'Incau, (Italy), M Lapeyre-Mestre, M Sáinz, M Donati, A Carvajal
Mon 131 Aluminium phosphide poisoning – a retrospective study
Nandlal Disania, (India), L Sharma, S Janani, BM Gupta
Mon 132 Management of acute myocardial infarction in France: Results from inclusion of a national cohort
Cécile Droz-Perroteau, (France), C Dureau-Pournin, D Thomas, N Danchin, J Tricoire, J Bénichou,
F Paillard, P Ducimetière, S Hercberg, H Maïzi, E Guiard, M-A Bernard, P Blin, N Moore
Mon 133 Analysis of pharmacotherapy for pregnant women in Primorye Region
Ekaterina Eliseeva, (Russian Federation), Y Feoktistova, L Lozinskaya
Mon 134 Medical prognosis of perioperative prophylaxis efficiency in cholecystectomy
Ekaterina Eliseeva, (Russian Federation), V Shevtsov
Mon 135 Clinical pharmacology outpatient clinic: outcomes and maternal characteristics associated with pregnancy
exposure to FDA category X drugs
Viktorija Erdeljic, (Croatia), I Francetic, K Makar-Ausperger, R Likic, M Radacic-Aumiler, D Juricic,
L Bielen
Mon 136 Prescription of potentially inappropriate medications: Comparison between internal medicine service
and geriatric unit
Leslie Escobar, (Chile), P Jara, M Jirón, M Rain, G Martinez, C Dechent
Mon 137 Mini-cases as a method to dynamize lectures of autonomic nervous system pharmacology in a medical
school
Magi Farre, (Spain), J-E Baños
Mon 138 Macro-study on-line of searching in internet for health and drug products: A social pharmacology
approach
Juan Antonio Formigos, (Spain), M Palmero, JL Alloza,
Mon 139 Quality of antibiotic prescribing in infant in ambulatory care
Kristina Garuoliene, (Lithuania), J Gulbinovic
Mon 140 Administrative complexities for a European observational study
Sinem Ezgi Gulmez, (France), S Lignot-Maleyran, S Micon, F Hamoud, C De Vries, M Sturkenboom,
P Blin, N Moore
Mon 141 SALOME: A pilot study to test causality assessment of drug-exposed acute liver failure cases using different
scales
Sinem Ezgi Gulmez, (France), GP Pageaux, D Larrey, S Lignot-Maleyran, F Hamoud, S Micon,
R Lassalle, J Jové, F Bissoli, Y Horsmans, J Bernuau, B Stricker, D Thorburn, P Blin, N Moore on
behalf of SALT-I team
Mon 142 Methods for improving compliance with medicine intake(MICMI): Pilot project to evaluate the ’Personal
Electronic Medicine profile’[PEM]
Philipp Harbig, (Denmark), I Barat, P Lund Nielsen, EM Damsgaard
Mon 143 Do vasodilating properties of amiodarone contribute to its antiarrthythmic action in clinical practice?
Apostolos Hatzitolios, (Greece), N Katsiki, G Ntaios, C Savopoulos, A Spiliopoulos, C Papadopoulos,
V Mirtsou-Fidani
170 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area